ResearcherUniversity of Illinois Hospital & Health Sciences SystemNo recent work listed
George I. Salti
Matched on OpenAlex author ID A5109138713. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2014: 1 trial · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper
Papers 3
- Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched St… Co-author DOI 10.1245/s10434-022-12347-w↗
- Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study. Co-author DOI 10.1245/s10434-020-09470-x↗
- Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population… Co-author DOI 10.1245/s10434-021-09823-0↗
Trials 1
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fadi S. Dahdaleh · 3 shared papers, 2021–2022 · strength 0.56
- Paper Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic… DOI 10.1245/s10434-022-12347-w↗
- Paper Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission … DOI 10.1245/s10434-020-09470-x↗
- Paper Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancre… DOI 10.1245/s10434-021-09823-0↗
- Sivesh Kathir Kamarajah · 3 shared papers, 2021–2022 · strength 0.56
- Paper Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic… DOI 10.1245/s10434-022-12347-w↗
- Paper Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission … DOI 10.1245/s10434-020-09470-x↗
- Paper Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancre… DOI 10.1245/s10434-021-09823-0↗
- Samer A. Naffouje · 3 shared papers, 2021–2022 · strength 0.56
- Paper Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic… DOI 10.1245/s10434-022-12347-w↗
- Paper Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission … DOI 10.1245/s10434-020-09470-x↗
- Paper Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancre… DOI 10.1245/s10434-021-09823-0↗
- Jason W. Denbo · 1 shared paper, 2022 · strength 0.20
- Steven Alan White · 1 shared paper, 2021 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.